Realcan Pharmaceutical Group Co., Ltd. at its Annual General Meeting of 2022 held on 19 May 2023, approved the appointment of Zhang Shoukai, Li Zhe and Wu Liyan as Non-Independent Director, Liu Xijun, Wang Jifa and Sun Kaoxiang as Independent Director and Zhang Yan as Non-Employee Supervisor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 CNY | +4.11% |
|
+3.64% | -30.28% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.28% | 469M | |
+26.95% | 76.24B | |
-4.87% | 23.36B | |
+15.06% | 8.76B | |
0.00% | 8.17B | |
-33.62% | 6.63B | |
+20.45% | 5.53B | |
+2.13% | 4.13B | |
-9.75% | 3.8B | |
-9.46% | 3.32B |
- Stock Market
- Equities
- 002589 Stock
- News Realcan Pharmaceutical Group Co., Ltd.
- Realcan Pharmaceutical Group Co., Ltd. Approves the Executive Appointments